Steve Martin
2021 - AmpliPhi Biosciences
In 2021, Steve Martin earned a total compensation of $739K as Chief Financial Officer at AmpliPhi Biosciences, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,320 |
|---|---|
| Option Awards | $219,898 |
| Salary | $370,800 |
| Total | $739,018 |
Martin received $370.8K in salary, accounting for 50% of the total pay in 2021.
Martin also received $148.3K in non-equity incentive plan and $219.9K in option awards.
Rankings
In 2021, Steve Martin's compensation ranked 9,724th out of 12,415 executives tracked by ExecPay. In other words, Martin earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,724 out of 12,415 | 22nd |
Division Manufacturing | 4,309 out of 5,505 | 22nd |
Major group Chemicals And Allied Products | 1,910 out of 2,375 | 20th |
Industry group Drugs | 1,695 out of 2,096 | 19th |
Industry Biological Products, Except Diagnostic Substances | 371 out of 449 | 17th |
Source: SEC filing on October 17, 2022.
Martin's colleagues
We found two more compensation records of executives who worked with Steve Martin at AmpliPhi Biosciences in 2021.